MedPath

Zistam-A

Brand Name: Zistam-A

Generic Name: Ambroxol Hydrochloride + Levocetirizine Hydrochloride

Expiring Soon
Registration Number

DRP-6452

Dosage Form

Sustained-Release Capsule

Issuance Date

May 13, 2022

Expiry Date

December 9, 2025

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength75mg/5mg
PackagingAluminum Foil Strip x 10's (Box of 10's)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial (Variation)
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Ambroxol HydrochlorideActive
Monograph: Ambroxol
Levocetirizine HydrochlorideActive
Monograph: Levocetirizine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform